seen from United States
seen from United States
seen from United States
seen from Philippines
seen from Belgium
seen from Canada
seen from United States
seen from United States
seen from France
seen from United States
seen from United States
seen from Germany
seen from China
seen from United States
seen from Belgium
seen from United States
seen from Germany
seen from Italy
seen from Belgium
seen from China
Metsera rates Novo Nordisk's new bid superior to Pfizer's offer
The logos of Danish pharmaceutical company Novo Nordisk, blockbuster diabetes and weight loss treatments Ozempic and Wegovy are visible outside the building as Novo Nordisk presents its annual report in Bagvaerd, Denmark, February 5, 2025. Mads Klaus Rasmussen | Afp | getty images Mesera said on tuesday novo nordiskNew bid for obesity biotech “Better” than the revised proposal. from PfizerThe…
Novo Nordisk's Launches New Insulin Affordability Offerings in the U.S.
Novo Nordisk’s Launches New Insulin Affordability Offerings in the U.S.
Novo Nordisk launched a handful of new insulin affordability offerings for people living in the U.S.
The new offerings include:
My$99Insulin: Patients can purchase up to three vials or two packs of FlexPen®/FlexTouch®/Penfill® pens of any combination of insulins from Novo Nordisk Inc. for $99
Follow-on brand insulins: Authorized generics of NovoLog® and NovoLog Mix® made by new Novo Nordisk A/S…
View On WordPress
Novo Nordisk's Ozempic® Lists on the Ontario Provincial Formulary
Novo Nordisk’s Ozempic® Lists on the Ontario Provincial Formulary
Novo Nordisk announced that Ozempic (semaglutide injection) is now publicly reimbursed in the province of Ontario for adults living with Type 2 diabetes.
Ozempic is available through many private insurance plans and publicly reimbursed through the following national and provincial government-sponsored drug benefit programs:
Non-Insured Health Benefits Program
Alberta
Prince Edward Island
Ontario
View On WordPress
